Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients

被引:53
作者
de Luis, D. A.
Aller, R.
Izaola, O.
Gonzalez Sagrado, M.
Conde, R.
机构
[1] Univ Valladolid, Hosp Rio Hortega, Inst Endocrinol & Nutr, Sch Med, Valladolid 47130, Spain
[2] Univ Valladolid, Hosp Rio Hortega, Unit Invest, Valladolid 47130, Spain
关键词
Insulin resistance; Low carbohydrate hypocaloric diet; Low fat hypocaloric diet; Nonalcoholic fatty liver disease; Obesity; STEATOHEPATITIS; ASSOCIATION; MORPHOLOGY; ORLISTAT; WEIGHT;
D O I
10.3305/nh.2010.25.5.4643
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: The aim of our study was to examine the changes in hypertransaminasemia after weight reduction in obese patients with and without NAFLD and the relation with insulin resistance. Research Methods: A population of 162 obese patients was randomly allocated to two groups: a) diet I (low fat) and b) diet II (low carbohydrate), dieting along 3 months. Patients were classified as group I (n=112) when serum ALT activity was normal or group II (NAFLD, n=30) when serum AI,T activity was (>=43 UI/L). Results: In control group with diet I, BMI, weight, fat mass, waist to hip ratio, waist circumference, systolic pressure, total cholesterol, LDL cholesterol, HOMA and insulin levels decreased. In NAFLD group with diet I improved the same parameters and glucose, triglycerides, ALT, AST, gamaglutamine transferase levels, too. In control group with diet II, BMI, weight, fat mass, waist to hip ratio, waist circumference, systolic pressure, total cholesterol, LDL cholesterol, HOMA and insulin levels decreased. In NAFLD group with diet improved the same parameters and glucose, triglycerides, ALT and gamaglutamine transferase levels, without statistical changes in AST. Conclusion: We showed that weight reduction secondary to two hypocaloric diets was associated with improvement in hipertransaminasemia and insulin resistance in NAFLD patients.
引用
收藏
页码:730 / 735
页数:6
相关论文
共 25 条
[1]   HEPATIC-EFFECTS OF DIETARY WEIGHT-LOSS IN MORBIDLY OBESE SUBJECTS [J].
ANDERSEN, T ;
GLUUD, C ;
FRANZMANN, MB ;
CHRISTOFFERSEN, P .
JOURNAL OF HEPATOLOGY, 1991, 12 (02) :224-229
[2]   Molecular mediators of hepatic steatosis and liver injury [J].
Browning, JD ;
Horton, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (02) :147-152
[3]   NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome [J].
Chitturi, S ;
Abeygunasekera, S ;
Farrell, GC ;
Holmes-Walker, J ;
Hui, JM ;
Fung, C ;
Karim, R ;
Lin, R ;
Samarasinghe, D ;
Liddle, C ;
Weltman, M ;
George, J .
HEPATOLOGY, 2002, 35 (02) :373-379
[4]   Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients [J].
Daniel, S ;
Ben-Menachem, T ;
Vasudevan, G ;
Ma, CK ;
Blumenkehl, M .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (10) :3010-3014
[5]   Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance [J].
de Luis, D. A. ;
Aller, R. ;
Izaola, O. ;
Gonzalez Sagrado, M. ;
Conde, R. ;
Gonzalez, J. M. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (01) :74-78
[6]   Influence of insulin resistance and adipocytokines on elevated serum alanine aminotransferase in obese patients [J].
de Luis, Daniel Antonio ;
Aller, Rocio ;
Izaola, Olatz ;
Sagrado, Manuel Gonzalez ;
Conde, Rosa ;
Bellido, Diego .
ARCHIVES OF MEDICAL RESEARCH, 2008, 39 (01) :110-114
[7]   EFFECT ON HEPATIC MORPHOLOGY OF TREATMENT OF OBESITY BY FASTING, REDUCING DIETS AND SMALL-BOWEL BYPASS [J].
DRENICK, EJ ;
SIMMONS, F ;
MURPHY, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (15) :829-&
[8]   A pilot study of orlistat treatment in obese, non-alcoholic steatohepatitis patients [J].
Harrison, SA ;
Fincke, C ;
Helinski, D ;
Torgerson, S ;
Hayashi, P .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (06) :623-628
[9]   Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin [J].
Knowler, WC ;
Barrett-Connor, E ;
Fowler, SE ;
Hamman, RF ;
Lachin, JM ;
Walker, EA ;
Nathan, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06) :393-403
[10]   BODY-FAT TOPOGRAPHY AS AN INDEPENDENT PREDICTOR OF FATTY LIVER [J].
KRAL, JG ;
SCHAFFNER, F ;
PIERSON, RN ;
WANG, J .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (05) :548-551